-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Protagonist Therapeutics, Raises Price Target to $115

Benzinga·12/08/2025 19:43:55
Listen to the news
Citigroup analyst Geoff Meacham maintains Protagonist Therapeutics (NASDAQ:PTGX) with a Buy and raises the price target from $98 to $115.